Publications
5600 Results
- Journal / Conference
- Blood Advances Apr 28;4(8):1683-1689
- Year
- 2020
- Research Committee(s)
- Leukemia
- PMID
- PMID32330241
- PMC
- PMC7189292
- Study Number(s)
- S0535
A Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients with Previously Untreated High-Risk Acute Promyelocytic Leukemia (SWOG S0535)
- Journal / Conference
- JAMA Network Open Jun 1;3(6):e2010651
- Year
- 2020
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID32478845
- PMC
- PMC7265094
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials [Research Letter]
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention Sep;29(9):1784-1791; Jun 16;cebp.0275.2020. doi: 10.1158/1055-9965.EPI-20-0275. Online ahead of print.
- Year
- 2020
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID32546605
- PMC
- PMC7483330
- Study Number(s)
- S0000, SWOG-9217
Genome-wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls From the PanScan and PanC4 Consortia
- Journal / Conference
- Clinical Cancer Research May 15;26(10):2434
- Year
- 2020
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID32414761
- Study Number(s)
- S1609
Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-Response [Response to Letter to Editor]
- Journal / Conference
- Blood Cancer Journal May 11;10(5):53
- Year
- 2020
- Research Committee(s)
- Myeloma
- PMID
- PMID32393732
- PMC
- PMC7214419
- Study Number(s)
- S0777
Longer Term Follow-up of the Randomized Phase III Trial SWOG S0777: Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT)
- Journal / Conference
- Clinical Cancer Research Aug 1;26(15):3969-3978; Apr 16. doi: 10.1158/1078-0432.CCR-19-1997. Online ahead of print
- Year
- 2020
- Research Committee(s)
- Myeloma
- PMID
- PMID32299820
- PMC
- PMC7415520
- Study Number(s)
- S1304
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma
- Journal / Conference
- Contemporary Clinical Trials Aug;95:106037. doi: 10.1016/j.cct.2020.106037. Epub 2020 May 30.
- Year
- 2020
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID32485324
- PMC
- PMC8171354
- Study Number(s)
- S1417CD
Design, Data Linkage, and Implementation Considerations in the First Cooperative Group Led Study Assessing Financial Outcomes in Cancer Patients and their Informal Caregivers
- Journal / Conference
- Journal of Patient Reported Outcomes Jul 8;4(1):54
- Year
- 2020
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- PMID32642992
- PMC
- PMC7343679
- Study Number(s)
- S1013
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013
- Journal / Conference
- Journal of Clinical Oncology Sep 10;38(26):3003-3011; Jul 13;JCO2000999. doi: 10.1200/JCO.20.00999. Online ahead of print
- Year
- 2020
- Research Committee(s)
- Lymphoma
- PMID
- PMID32658627
- PMC
- PMC7479758
- Study Number(s)
- S1001
Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001
- Journal / Conference
- Prostate Aug;80(11):895-905
- Year
- 2020
- Research Committee(s)
- Cancer Control
- PMID
- PMID32506665
- PMC
- PMC7384586
- Study Number(s)
- SWOG-9217